rtStar™ cDNA Synthesis Products

rtStar™ cDNA Synthesis products offer four types of kits to meet the needs of studying different RNAs. They are suitable for reverse transcribing total RNAs, tRNAs, miRNAs and other small RNAs, respectively.

Benefits

• Complete kit—all the components for the RT reaction are included.

• RNA Spike-in provided to monitor cDNA synthesis efficiency.

• Have a high efficiency and precision during cDNA synthesis.

• Satisfy different needs of customers—suitable for total RNAs, miRNAs, tRNAs and other small RNAs.

Product NameCatalog No.SizePrice
rtStar™ First-Strand cDNA Synthesis KitAS-FS-00112 reactions$128.00
rtStar™ First-Strand cDNA Synthesis Kit (3’ and 5’ adaptor)6 reactions$287.00
rtStar™ First-Strand cDNA Synthesis Kit (3’ and 5’ adaptor)6 reactions$419.00
rtStar™ tRNA Pretreatment & First-Strand cDNA Synthesis Kit12 reactions$360.00
rtStar™ PreAMP cDNA Synthesis for Small RNAAS-FS-0066 reactions$314.00
rtStar™ PreAMP cDNA Synthesis for Small RNAAS-FS-006-0212 reactions$482.00

cDNA_synthesis1

For PolyA( /-) mRNAs, lncRNAs, or total RNAs.
Required for lncRNAmRNA,snoRNA PCR Arrays
For distinguishing small RNAs from their precursors.
Required for
tRF&tiRNA,miRNA PCR Arrays
For modified tRNAs with included demethylation.
Required for tRNA PCR Arrays
For low-input small RNAs.
Required for tRF&tiRNAmiRNA PCR Arrays 

 

PAX translocations remodel mitochondrial metabolism through altered leucine usage in rhabdomyosarcoma. Bhargab Kalita, et al. Cell, 2025

TRMT6-mediated tRNA m1A modification acts as a translational checkpoint of histone synthesis and facilitates colorectal cancer progression. Tao E, et al. Nature Cancer, 2025

A novel 5’tRNA-derived fragment tRF-Tyr inhibits tumor progression by targeting hnRNPD in gastric cancer. Cui H, et al. Cell Communication and Signaling, 2025

Non-coding RNAs secreted by renal cancer include piR_004153 that promotes migration of mesenchymal stromal cells. Joanna Boguslawska, et al. Cell Communication and Signaling, 2025

Valine aminoacyl-tRNA synthetase promotes therapy resistance in melanoma. El-Hachem N ,et al. Nature Cell Biology, 2024

Chemotherapeutic agents and leucine deprivation induce codon-biased aberrant protein production in cancer Adva Kochavi, et al. Nucleic Acids Research, 2024

Nucleotidyltransferase toxin MenT extends aminoacyl acceptor ends of serine tRNAs to control Mycobacterium tuberculosis growth. Xu X, et al. Nature Communications, 2024

A specific tRNA half, 5’tiRNA-His-GTG, responds to hypoxia via the HIF1a/ANG axis and promotes colorectal cancer progression by regulating LATS2. Tao E W, et al. Journal of Experimental & Clinical Cancer Research, 2021

Gene-Specific Control of tRNA Expression by RNA Polymerase II. Gerber A, et al. Molecular Cell, 2020

Quantitative tRNA-sequencing uncovers metazoan tissue-specific tRNA regulation. Pinkard O,  et al. Nature Communications, 2020

tRNA-based prognostic score in predicting survival outcomes of lung adenocarcinomas. Kuang M, et al. International journal of cancer, 2019

Expression analysis of transfer RNA-derived fragments in the blood of patients with moyamoya disease: A preliminary study. Wang C, et al. Molecular medicine reports, 2019

Systematic Analysis of tRNA-Derived Small RNAs Reveals Novel Potential Therapeutic Targets of Traditional Chinese Medicine (Buyang-Huanwu-Decoction) on Intracerebral Hemorrhage. Li P, et al. International Journal of Biological Sciences, 2019

DNA damage-induced cell death relies on SLFN11-dependent cleavage of distinct type II tRNAs. Li M, et al. Nature Structural & Molecular Biology, 2018

Kallistatin Inhibits Atherosclerotic Inflammation by Regulating Macrophage Polarization. Li B,et al. Human gene therapy, 2018